ArticleCancers2022

Grade 3-4 Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer (NSCLC) Patients Are Correlated with Better Outcome: A Real-Life Observational Study.

Nadia Guezour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.